Use of prion conversion modulating agents

Details for Australian Patent Application No. 2004248302 (hide)

Owner Merck Serono SA

Inventors Maundrell, Kinsey; Soto-Jara, Claudio

Agent Griffith Hack

Pub. Number AU-B-2004248302

PCT Pub. Number WO2004/111652

Priority 03101795.7 19.06.03 EP

Filing date 18 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 30 July 2009

International Classifications

A61K 31/00 (2006.01)

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/111652 Priority application(s): WO2004/111652

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

30 July 2009 Application Accepted

  Published as AU-B-2004248302

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004248325-Copying copy protected optical discs

2004248292-Remote control method and device controlled from communicating terminals